Anticancer effects of imidazole nucleus in hepatocellular carcinoma cell lines via the inhibition of AKT and ERK1/2 signaling pathways

MLA

Erdem Goker, and Erkan Kahraman. Anticancer Effects of Imidazole Nucleus in Hepatocellular Carcinoma Cell Lines via the Inhibition of AKT and ERK1/2 Signaling Pathways. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a5542e352520a9aa8933d5830aa5ef1&authtype=sso&custid=ns315887.

APA

Erdem Goker, & Erkan Kahraman. (2022). Anticancer effects of imidazole nucleus in hepatocellular carcinoma cell lines via the inhibition of AKT and ERK1/2 signaling pathways.

Chicago

Erdem Goker, and Erkan Kahraman. 2022. “Anticancer Effects of Imidazole Nucleus in Hepatocellular Carcinoma Cell Lines via the Inhibition of AKT and ERK1/2 Signaling Pathways,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a5542e352520a9aa8933d5830aa5ef1&authtype=sso&custid=ns315887.